At a glance
ClinicalIndex Comparison RecordN/ACompleted· 88 enrolled
Drug / intervention
Invigor A (test) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the CooperVision, Inc. Invigor A and Invigor B Silicone Hydrogel Daily Wear Contact Lenses When Used for Frequent Replacement for Up to One (1) Month of Daily Wear
In Brief
A clinical study evaluating Invigor A (test) and Invigor B (control) for Myopia and 2 related conditions. Completed, enrolled 88 participants across 6 sites.
Detailed Summary
The aim of the study is to evaluate if the performance of Invigor A is substantially equivalent to Invigor B contact lenses when used in a one month recommended replacement, daily wear modality.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia, Hyperopia, Astigmatism
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartOct 2018
First PostedOct 2018
Primary CompletionJan 2019
Study CompletionJun 2019
TodayJul 2026
First PostedOct 29, 2018
Enrollment StartOct 10, 2018
Primary CompletionJan 18, 2019
Study CompletionJun 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.7 years ago
Interventions
Invigor A (test)device
silicone hydrogel lens
Invigor B (control)device
silicone hydrogel lens